Stockreport

Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Evaxion developed a genetic adjuvant technology that boosts the immune responses of viral, bacterial and cancer vaccinesPreclinically validated for both DNA and mRNA vac [Read more]